Injectomat - syringe 50ml - without cannula Montenegro - croata - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

injectomat - syringe 50ml - without cannula

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - medicinska sredstva za jednokratnu upotrebu

Cornwall sterile disposable syringes for single use withwithout needles Two parts Montenegro - croata - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

cornwall sterile disposable syringes for single use withwithout needles two parts

tehmar promet doo beograd dio stranog druŠtva u podgorici - medicinska sredstva za jednokratnu upotrebu

Lancets without safety systems single use Montenegro - croata - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

lancets without safety systems single use

druŠtvo za trgovinu, promet i usluge "pontera pharma solutions" doo podgorica - druga medicinska sredstva

Sterile Gauze Swab without X-ray Montenegro - croata - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

sterile gauze swab without x-ray

d.o.o. "inter pharm" d.o.o. druŠtvo za trgovinu na veliko farmaceutskim proizvodima podgorica - medicinska sredstva za jednokratnu upotrebu

Dimension RxL Max (with or without HM) Montenegro - croata - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

dimension rxl max (with or without hm)

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - in vitro dijagnostička medicinska sredstva

HI-TORQUE BALANCE MIDDLEWEIGHT UNIVERSAL II Guide Wire Tip: with TURBOCOAT Hydrophilic Coating with TURBOCOAT Hydrophilic Coating without Marker Montenegro - croata - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

hi-torque balance middleweight universal ii guide wire tip: with turbocoat hydrophilic coating with turbocoat hydrophilic coating without marker

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - medicinska sredstva za jednokratnu upotrebu

Winmed disposable syringe two-parts without needle Montenegro - croata - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

winmed disposable syringe two-parts without needle

tehmar promet doo beograd dio stranog druŠtva u podgorici - medicinska sredstva za jednokratnu upotrebu

Dupixent Unión Europea - croata - EMA (European Medicines Agency)

dupixent

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenti za dermatitis, isključujući kortikosteroide - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Mekinist Unión Europea - croata - EMA (European Medicines Agency)

mekinist

novartis europharm limited - trametinib - melanoma - antineoplastična sredstva - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 i 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. Немелкоклеточный rak pluća (НМРЛ)trametinib u kombinaciji s dabrafenib indiciran za liječenje odraslih bolesnika s preliminarnim non-mali raka pluća stanice s Браф mutacija v600 daleko .

DULAMESH PLUS, DULAMESH PLUS WITH HOLES I MYCROMESH PLUS Croacia - croata - HALMED (Agencija za lijekove i medicinske proizvode)

dulamesh plus, dulamesh plus with holes i mycromesh plus

tipex d.o.o., zagreb - mrežica za herniju